MultiHance® in the dynamic phase of contrast enhancement: A pictorial assessment

Journal of Computer Assisted Tomography

Volumn 23, Issue SUPPL., 1999, Pages

  Grazioli, Luigi ^b   Kirchin, Miles ^a   Pirovano, Gianpaolo ^a   Spinazzi, Alberto ^a  

^a Bracco SpA   (Italy)

^b SPEDALI CIVILI   (Italy)

Author keywords

Dynamic MRI; Gadobenate dimeglumine; Liver neoplasms

Indexed keywords

IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING;

CHOLANGIOCARCINOMA; CONTRAST ENHANCEMENT; DYNAMIC MAGNETIC RESONANCE IMAGING; DYNAMIC MRI; DYNAMIC PHASE; FOCAL LIVER LESIONS; GADOBENATE DIMEGLUMINE; HEPATOBILIARY; HEPATOCELLULAR CARCINOMA; LIVER NEOPLASMS;

TUMORS;

GADOBENATE DIMEGLUMINE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOBENIC ACID; GADOLINIUM; MEGLUMINE; ORGANOMETALLIC COMPOUND;

BILE DUCT CARCINOMA; CLINICAL TRIAL; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER TUMOR; MULTICENTER STUDY; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; ADENOMA; ARTICLE; BILE DUCT TUMOR; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMANGIOMA; INTRAHEPATIC BILE DUCT; INTRAVENOUS DRUG ADMINISTRATION; LIVER DISEASE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADENOMA; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FOCAL NODULAR HYPERPLASIA; GADOLINIUM; HEMANGIOMA; HUMANS; INJECTIONS, INTRAVENOUS; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES;

EID: 0033376476     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199911001-00009     Document Type: Conference Paper

References (21)

1. Baron RL. Detection of liver neoplasms: techniques and outcomes. Abdom Imaging 1994;19:320-4.
2. Baker ME, Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995;197:329-37.
3. Karhunen PJ. Benign hepatic tumors and tumor-like conditions in men. J Clin Pathol 1986;39:183-8.
4. Hamm B, Thoeni RF, Gould RG, et al. Focal liver lesions: characterization with nonenhanced and dynamic contrast-material-enhanced MR imaging. Radiology 1994;190:417-23.
5. Van Beers B, Demeure R, Pringot J, et al. Dynamic spin echo imaging with Gd-DTPA: value in the differentiation of hepatic tumors. AJR 1990; 54:515-9.
6. Hamm B, Mahfouz AE, Taupitz M, et al. Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? Radiology 1997;202:677-82.
7. Peterson MS, Baron RL, Murakami T. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 1996;201:337-45.
8. Kirchin MA, Pirovano G, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA): an overview. Invest Radiol 1998;33:798-809.
9. Spinazzi A, Lorusso V, Pirovano G, Kirchin MA. Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in non-patient and patient volunteers. Acad Radiol 1999;6:282-91.
10. Spinazzi A, Lorusso V, Pirovano GP, et al. MultiHance® clinical pharmacology: biodistribution and MR enhancement of the liver. Acad Radiol 1998;5:S86-9.
11. Rosati G, Pirovano G, Spinazzi A. Interim results of phase II clinical testing of gadobenate dimeglumine. Invest Radiol 1994;29:S183-5.
12. Caudana R, Morana G, Pirovano G, et al. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA) - preliminary results of phase II clinical application. Radiology 1997;203:513-20.
13. Peterstein J, Spinazzi A, Giovagnoni A, et al. Evaluation of the efficacy of gadobenate dimeglumine in magnetic resonance imaging of focal liver lesions: a multicenter phase III clinical study. Radiology 2000 In press
14. Awaya H, Ito K, Honjo K, Fujita T, Matsumoto T, Matsunaga N. Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay. Clin Imaging 1998; 22;180-7.
15. Soyer P, Laissy JP, Sibert A, Menu Y. Dynamic gadolinium-DOTA-enhanced MR imaging at 1.0T: value in the differentiation of hepatic tumors. Clin Imaging 1996;20:118-25.
16. Hamm B, Fischer E, Taupitz M. Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging. J Comput Assist Tomogr 1990;14:205-16.
17. Whitney WS, Herfkens RJ, Jeffrey RB, et al. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangioma from malignancies at 1.5 T. Radiology 1993;189:863-70.
18. Mahfouz AE, Hamm B, Taupitz M, Wolf KJ. Hypervascular liver lesions: Differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology 1993;186:133-8.
19. Mathiey D, Rahmouni A, Anglade MC, et al. Focal nodular hyperplasia of the liver: assessment with contrast-enhanced turboflash MR imaging. Radiology 1991;180:25-30.
20. Chung KY, Mayo-Smith WW, Saini S, Rahmouni A, Golli M, Mathieu D. Hepatocellular adenoma: MR imaging features with pathologic correlation. Am J Roentgenol 1995;165:303-8.
21. Quillin SP, Atilla S, Brown JJ, Borello JA, Yu CY, Pilgram TK. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions. Magn Reson Imaging 1997;15:275-85.